Search

everythinglearnresearchcommunity

for

Search:↓

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Studying premature aging syndromes helps understand human aging and suggests potential treatments.

CREB, a protein that can promote cancer traits, is controlled by β-catenin in skin cancer cells.

2-Methoxyestradiol causes cancer cell death by activating specific pathways, but androgens can block this effect.

Certain genetic markers can indicate a person's risk of developing prostate cancer.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Targeting Sirt1 can reduce androgen levels and slow glioblastoma growth.

The hair keratin gene KRT81 is found in both normal and breast cancer cells and helps them invade surrounding tissues.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

The Hr protein binds to DNA, interacts with p53, and affects cell cycle genes.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Impaired LEF1 activation speeds up skin cell development in Hutchinson-Gilford Progeria Syndrome.

Kidney cancer cells without folliculin are more sensitive to radiation due to increased self-eating cell death.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Understanding EGFR roles could lead to new hair loss treatments.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Chemotherapy causes permanent hair follicle damage by triggering stem cell loss.

A rare adrenal tumor in a 14-year-old girl caused male-like symptoms and was successfully removed.

Overexpressing 14-3-3σ in mice skin reduces cell growth and hair density.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Different types of skin gland tumors have unique genetic traits, which can guide personalized treatments.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Targeting the Smoothened receptor shows promise for treating certain cancers.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

The treatment was effective for advanced non-Hodgkin's lymphomas.

Genetically modified cells improved skin wound healing in rats.

Finasteride, selenium, and vitamin E may help prevent prostate cancer.

Activating mitophagy may help manage a key immune response involved in the hair loss condition alopecia areata.